Shanghai Pharmaceuticals' Unit Gets Nod for Raw Drug Material for Hypertension, Heart Disease; Shares Down 3%
Shanghai Pharmaceuticals' Unit Gets Nod for Raw Drug Material for Hypertension, Heart Disease; Shares Down 3%
上海製藥公司獲得高血壓、心臟病原料的點頭；股價下跌3％
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊